Rocket Pharmaceuticals (RCKT) News Today $13.04 -0.12 (-0.91%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Chardan Capital Reaffirms "Buy" Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)November 21 at 2:53 AM | americanbankingnews.comRocket Pharmaceuticals Reports Positive Results for Danon Disease ProgramNovember 20 at 5:13 AM | americanbankingnews.comRocket Pharmaceuticals (NASDAQ:RCKT) Given "Buy" Rating at Canaccord Genuity GroupNovember 20 at 3:49 AM | americanbankingnews.comRocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: AnalystNovember 19 at 2:47 PM | benzinga.comPromising Clinical Developments in Rocket Pharmaceuticals Justify Buy Rating and $52 Target PriceNovember 19 at 11:59 AM | markets.businessinsider.comTD Cowen Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT)November 19 at 11:59 AM | markets.businessinsider.comLeerink Partners Issues Pessimistic Forecast for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock PriceLeerink Partners decreased their price target on shares of Rocket Pharmaceuticals from $46.00 to $44.00 and set an "outperform" rating on the stock in a research report on Tuesday.November 19 at 11:17 AM | marketbeat.comCantor Fitzgerald Reiterates Overweight Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)Cantor Fitzgerald reissued an "overweight" rating and issued a $65.00 target price on shares of Rocket Pharmaceuticals in a report on Tuesday.November 19 at 9:43 AM | marketbeat.comRocket Pharmaceuticals' (RCKT) Buy Rating Reiterated at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and set a $52.00 price objective on shares of Rocket Pharmaceuticals in a report on Tuesday.November 19 at 8:34 AM | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Bought by First Turn Management LLCFirst Turn Management LLC grew its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 10.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 621,306 shares of the biotechnology compNovember 19 at 6:08 AM | marketbeat.comRocket Pharmaceuticals has not initiated enrollment in Phase 2 RP-L301 studyNovember 19 at 1:57 AM | markets.businessinsider.comRocket Pharmaceuticals’ RP-A501 Shows Promising Long-Term Efficacy and Safety in Danon Disease Treatment: Buy Rating AffirmedNovember 19 at 1:57 AM | markets.businessinsider.comRocket Pharma Stock Slips Despite New Long-Term Data On Phase-I Study; Retail Sentiment SlidesNovember 18 at 8:56 PM | msn.comRocket Pharmaceuticals announces publication of Phase 1 RP-A501 long-term dataNovember 18 at 3:54 PM | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week Low - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week Low - Here's WhyNovember 18 at 11:09 AM | marketbeat.comScotiabank Sticks to Its Buy Rating for Rocket Pharmaceuticals (RCKT)November 16, 2024 | markets.businessinsider.comChardan Capital Has Strong Forecast for RCKT FY2024 EarningsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Stock analysts at Chardan Capital increased their FY2024 EPS estimates for Rocket Pharmaceuticals in a research note issued to investors on Monday, November 11th. Chardan Capital analyst Y. Livshits now forecasts that the biotechnology coNovember 14, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Earns Buy Rating from Chardan CapitalNovember 13, 2024 | americanbankingnews.comPrivium Fund Management B.V. Has $5.45 Million Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Privium Fund Management B.V. raised its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 17.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 294,800 shares of the biNovember 10, 2024 | marketbeat.comJ.P. Morgan Remains a Buy on Rocket Pharmaceuticals (RCKT)November 9, 2024 | markets.businessinsider.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have been given an average rating of "Moderate Buy" by the ten research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and nine have issued a buy rating on tNovember 9, 2024 | marketbeat.comRocket Pharmaceuticals: Strong Buy Rating Backed by Promising AAV and LV Franchise Developments and Solid Financial PositionNovember 9, 2024 | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Receives "Buy" Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $52.00 target price on shares of Rocket Pharmaceuticals in a research report on Friday.November 8, 2024 | marketbeat.comRocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent ProgressNovember 7, 2024 | finance.yahoo.comTaiwan Says It Receives First High-tech Rocket Systems From USNovember 6, 2024 | barrons.comRocket CRM Introduces Enhanced Sales Funnel to Streamline Customer Journeys and Optimize Conversion for BusinessesNovember 5, 2024 | theglobeandmail.comHarbor Capital Advisors Inc. Has $3.11 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Harbor Capital Advisors Inc. increased its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 73.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 168,506 shares of the biotechnology cNovember 5, 2024 | marketbeat.comRussia Launches Soyuz Rocket With Dozens of Satellites, Including Two From IranNovember 4, 2024 | usnews.comWatch Rocket Lab launch mystery mission early on Nov. 4November 4, 2024 | msn.comUkraine's Rocket Forces and Artillery Day to be celebrated in early DecemberNovember 2, 2024 | yahoo.comWaves of rocket fire from Lebanon hit Israel, killing 7 in deadliest strikes since Israeli invasionOctober 31, 2024 | ca.news.yahoo.comRevenue Rocket Advises Uptime Legal Systems in Strategic Acquisition of LexCloudOctober 31, 2024 | finance.yahoo.comThe Brabus Rocket GTS Is a 986-HP Clownshoe Made From a Mercedes SLOctober 26, 2024 | msn.comRocket Mortgage sued for racial discrimination against Black Denver homeownerOctober 22, 2024 | msn.comChina's Xi Inspects Nuclear-Armed Rocket Force After Missile TestOctober 22, 2024 | msn.comDOJ sues Rocket Mortgage after Black homeowner got lowball appraisalOctober 21, 2024 | msn.comRocket Mortgage accused of discriminating against Black homeowner who sought to refinanceOctober 21, 2024 | detroitnews.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.3% - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.3% - Here's What HappenedOctober 21, 2024 | marketbeat.comAlex Barré-Boulet and Joshua Roy score two goals each in Rocket winOctober 19, 2024 | msn.comChina’s Xi inspects PLA's Rocket Force, emphasizes upgrading deterrence and combat capabilitiesOctober 19, 2024 | msn.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - Time to Buy?Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - What's Next?October 16, 2024 | marketbeat.comMusk's SpaceX Sues California Panel, Alleges Political Bias Over Rocket LaunchesOctober 16, 2024 | usnews.comRocket Pharmaceuticals (NASDAQ:RCKT) Receives New Coverage from Analysts at ScotiabankScotiabank assumed coverage on Rocket Pharmaceuticals in a research report on Wednesday. They set a "sector outperform" rating on the stock.October 16, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and eight haveOctober 15, 2024 | marketbeat.comFortnite Is Stopping Rocket Racing "Themed Updates" After Less Than A YearOctober 14, 2024 | msn.comRocket Driver gets a release dateOctober 13, 2024 | msn.comLaval Rocket Announce Leadership GroupOctober 13, 2024 | sports.yahoo.comSpaceX Launches Its Mega Starship Rocket. This Time, Mechanical Arms Will Try to Catch It at LandingOctober 13, 2024 | msn.comIran Sends Satellites to Russia for Rocket Launch, Tasnim ReportsOctober 12, 2024 | usnews.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 3.8% - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 3.8% - What's Next?October 9, 2024 | marketbeat.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. RCKT Media Mentions By Week RCKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼0.320.45▲Average Medical News Sentiment RCKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼247▲RCKT Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AUPH News Today RCUS News Today YMAB News Today MRSN News Today AMRN News Today HRTX News Today GBIO News Today BHVN News Today ACLX News Today BBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCKT Stock Alerts